Dr. Somaiah on NY-ESO-1 Expression in Soft Tissue Sarcoma

Neeta Somaiah, MD
Published: Thursday, Jul 06, 2017



Neeta Somaiah, MD, assistant professor, Department of Sarcoma Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, discusses the expression of NY-ESO-1 in patients with soft tissue sarcoma.

There were previous studies looking at the NY-ESO-1 expression across different sarcoma subtypes, explains Somaiah. However, the percentage of NY-ESO-1 expression in those other subtypes is around 30% whereas it is around 80% to 100% for soft tissue sarcoma.
 


Neeta Somaiah, MD, assistant professor, Department of Sarcoma Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, discusses the expression of NY-ESO-1 in patients with soft tissue sarcoma.

There were previous studies looking at the NY-ESO-1 expression across different sarcoma subtypes, explains Somaiah. However, the percentage of NY-ESO-1 expression in those other subtypes is around 30% whereas it is around 80% to 100% for soft tissue sarcoma.
 

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Moving Forward From the Status Quo for the Treatment of Soft Tissue Sarcoma: Key Questions & New Answers to Optimize OutcomesAug 16, 20181.5
Community Practice Connections™: Personalized Sequencing in Castration-Resistant Prostate Cancer: Bridging the Latest Evidence to the Bedside in Clinical ManagementAug 25, 20181.5
Publication Bottom Border
Border Publication
x